Manchester Capital Management LLC Pfizer Inc Transaction History

Manchester Capital Management LLC

$703 Million
Q3 2025

A detailed history of Manchester Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Manchester Capital Management LLC holds 47,689 shares of PFE stock, worth $1.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

47,689

Previous 50,005 4.63%

Holding current value

$1.2 Million

Previous $1.21 Million 0.25%

% of portfolio

0.17%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$23.29 - $25.88 $53,939 - $59,938	-2,316 Reduced 4.63%	47,689 $1.22 Million
Q2 2025 Aug 12, 2025	BUY	$21.59 - $24.84 $50,973 - $58,647	2,361 Added 4.96%	50,005 $1.21 Million
Q1 2025 May 09, 2025	BUY	$25.01 - $27.13 $12,680 - $13,754	507 Added 1.08%	47,644 $1.21 Million
Q4 2024 Jan 30, 2025	BUY	$24.8 - $30.19 $82,484 - $100,411	3,326 Added 7.59%	47,137 $1.25 Million
Q3 2024 Nov 05, 2024	BUY	$27.7 - $31.39 $8,337 - $9,448	301 Added 0.69%	43,811 $1.27 Million

Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $9,523 - $11,159	377 Added 0.87%	43,510 $1.22 Million
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $6,394 - $7,343	247 Added 0.58%	43,133 $1.2 Million
Q4 2023 Feb 08, 2024	SELL	$26.13 - $33.94 $93,388 - $121,301	-3,574 Reduced 7.69%	42,886 $1.23 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $6,514 - $7,614	-203 Reduced 0.44%	46,460 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $211,590 - $244,805	5,858 Added 14.36%	46,663 $1.71 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $3,111 - $4,051	79 Added 0.19%	40,805 $1.66 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $131,345 - $171,457	-3,146 Reduced 7.17%	40,726 $2.09 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $54,787 - $66,881	1,252 Added 2.94%	43,872 $1.92 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $93,478 - $110,836	2,009 Added 4.95%	42,620 $2.24 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $129,472 - $160,432	-2,830 Reduced 6.51%	40,611 $2.1 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $82,846 - $122,806	-2,005 Reduced 4.41%	43,441 $2.57 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $107,662 - $138,302	2,743 Added 6.42%	45,446 $1.96 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $70,599 - $79,976	1,966 Added 4.83%	42,703 $1.67 Million
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $44,876 - $50,611	1,340 Added 3.4%	40,737 $1.48 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $44,280 - $56,306	1,323 Added 3.47%	39,397 $1.45 Million
Q3 2020 Oct 27, 2020	SELL	$31.75 - $37.25 $287,051 - $336,777	-9,041 Reduced 19.19%	38,074 $1.4 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $82,225 - $117,482	3,042 Added 6.9%	47,115 $1.54 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $18,040 - $20,473	548 Added 1.26%	44,073 $1.73 Million
Q3 2019 Nov 04, 2019	SELL	$32.49 - $42.13 $12,898 - $16,725	-397 Reduced 0.9%	43,525 $1.56 Million
Q2 2019 Aug 05, 2019	SELL	$36.98 - $41.52 $36,980 - $41,520	-1,000 Reduced 2.23%	43,922 $1.9 Million
Q1 2019 May 08, 2019	BUY	$37.5 - $41.2 $91,837 - $100,898	2,449 Added 5.77%	44,922 $1.91 Million
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $433,489 - $462,143	13,144 Added 44.82%	42,473 $1.54 Million
Q1 2018 May 07, 2018	SELL	$31.91 - $37.02 $15,699 - $18,213	-492 Reduced 1.65%	29,329 $1.04 Million
Q4 2017 Feb 08, 2018	BUY	$33.26 - $35.29 $37,417 - $39,701	1,125 Added 3.92%	29,821 $1.08 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $889,576 - $979,968	28,696	28,696 $1.02 Million

Others Institutions Holding PFE

# of Institutions

3,372

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manchester Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Manchester Capital Management LLC with notifications on news.

Account

Manchester Capital Management LLC Pfizer Inc Transaction History